Clinical Trial Update: DEtection of Cellular Inflammation With FERumoxytol in the HEART [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update confirms completion of Phase 2 and Phase 3 studies evaluating ferumoxytol-enhanced imaging to detect cellular inflammation in cardiac …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis
• Myocarditis

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: University of Edinburgh | Conditions: Cardiac Transplant, Cardiac Sarcoid | Phase 2, Phase 3 | Status: COMPLETED